RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements Cannabis Investing News
Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study Pharmaceutical Investing
Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs Cannabis Investing News
WELL Health Announces Automated Phone, SMS and Web-based COVID-19 Triage Tool for Canadians Medical Device Investing
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A Cannabis Investing News
Cardiol Therapeutics CEO David Elsley: Shoppers Supply Agreement a Significant Milestone Pharmaceutical Investing
RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution Cannabis Investing News
Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19 Pharmaceutical Investing
Revive Therapeutics Appoints Dr. David Boulware, MD, as Scientific Advisor for Infectious Diseases including COVID-19 Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
